Tata India Pharma & Healthcare Fund vs Mirae Asset Healthcare Fund compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1296 Cr | ₹2762 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 02 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare |
| Turn Over | 26.49% | 15% |
| Expense Ratio | 2.14 | 1.92 |
| Manager | Meeta Shetty | Vrijesh Kasera |
| ISIN Code | INF277K016A9 | INF769K01EA2 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | 1.62% | 1.77% |
| 6 Month | 4.67% | 5.49% |
| 1 Year | 0.03% | 0.41% |
| 3 Year | 21.54% | 20.42% |
| 5 Year | 18.03% | 17.85% |
SIP Return Analysis
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | 0.44% | 0.29% |
| 1 Year | 4.04% | 4.53% |
| 3 Year | 18.74% | 18.55% |
| 5 Year | 17.23% | 16.52% |
Rolling Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 9.76% | 20.38% |
| 3 Year | 18.6% | 19.77% |
| 5 Year | 15.32% | 23.61% |
Risk Management
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 16.04% | 16.44% |
| Sharp | 0.90% | 0.82% |
| Beta | 0.97% | 1.00% |
| Alpha | -0.83% | -2.05% |
Fund Managers
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Meeta Shetty | Vrijesh Kasera |
| Total AUM | ₹17847 Cr | ₹12061 Cr |
| Funds Managed | 5 | 4 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 4.14 | 4.78 |
| Large Cap | 25.14 | 32.37 |
| Mid Cap | 37.44 | 36.93 |
| Small Cap | 33.28 | 25.92 |
Sector Allocation
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 1.72 | 0.11 |
| Healthcare | 94.07 | 98.51 |
| Basic Materials | 2.64 | 1.38 |
| Financial Services | 1.58 | - |
Top Comparisons
Nippon India Pharma Fund-Growth Plan-Growth Option
3Y Returns20.87%
UTI Healthcare Fund - Regular Plan - Growth Option
3Y Returns23.73%
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns19.04%
Nippon India Focused Fund - Growth Plan -Growth Option
3Y Returns14.11%
HDFC Corporate Bond Fund - Growth Option
3Y Returns7.91%
Sundaram Corporate Bond Fund Regular Plan- Growth
3Y Returns7.46%
HDFC ELSS Tax saver Fund - Growth Plan
3Y Returns21.33%
Axis ELSS Tax Saver Fund - Regular Plan - Growth
3Y Returns13.64%